» Articles » PMID: 12705865

Peroxisome-proliferator-activated Receptor Delta Activates Fat Metabolism to Prevent Obesity

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2003 Apr 23
PMID 12705865
Citations 461
Authors
Affiliations
Soon will be listed here.
Abstract

In contrast to the well-established roles of PPARgamma and PPARalpha in lipid metabolism, little is known for PPARdelta in this process. We show here that targeted activation of PPARdelta in adipose tissue specifically induces expression of genes required for fatty acid oxidation and energy dissipation, which in turn leads to improved lipid profiles and reduced adiposity. Importantly, these animals are completely resistant to both high-fat diet-induced and genetically predisposed (Lepr(db/db)) obesity. As predicted, acute treatment of Lepr(db/db) mice with a PPARdelta agonist depletes lipid accumulation. In parallel, PPARdelta-deficient mice challenged with high-fat diet show reduced energy uncoupling and are prone to obesity. In vitro, activation of PPARdelta in adipocytes and skeletal muscle cells promotes fatty acid oxidation and utilization. Our findings suggest that PPARdelta serves as a widespread regulator of fat burning and identify PPARdelta as a potential target in treatment of obesity and its associated disorders.

Citing Articles

Autophagy and the peroxisome proliferator-activated receptor signaling pathway: A molecular ballet in lipid metabolism and homeostasis.

Kiani P, Khodadadi E, Nikdasti A, Yarahmadi S, Gheibi M, Yousefi Z Mol Cell Biochem. 2025; .

PMID: 39891864 DOI: 10.1007/s11010-025-05207-0.


Omega-3 Fatty Acid and Vitamin D Supplementations Partially Reversed Metabolic Disorders and Restored Gut Microbiota in Obese Wistar Rats.

Le Jan D, Siliman Misha M, Destrumelle S, Terceve O, Thorin C, Larcher T Biology (Basel). 2025; 13(12.

PMID: 39765737 PMC: 11673857. DOI: 10.3390/biology13121070.


Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts.

Clayton S, Mizener A, Whetsell M, Rentz L, Meadows E, Geldenhuys W Cancers (Basel). 2024; 16(21).

PMID: 39518077 PMC: 11544806. DOI: 10.3390/cancers16213640.


PPARs: modulating lipotoxicity and thus inhibiting fibrosis.

Li W, Zhang C, Wang J Hormones (Athens). 2024; .

PMID: 39500811 DOI: 10.1007/s42000-024-00612-4.


Variants in - are related to diabetic kidney disease in Chinese Han patients with type 2 diabetes mellitus.

Song J, Zhuang Y, Pan X, Chen Y, Xie F Heliyon. 2024; 10(15):e35289.

PMID: 39161836 PMC: 11332863. DOI: 10.1016/j.heliyon.2024.e35289.